Researchers at Duke-NUS Medical School have identified a molecular switch controlled by the protein GATA6 that determines whether pancreatic cancer cells respond to chemotherapy or become resistant.

When researchers first observed the presence of circular RNAs in the 1970s, they were an inexplicable biological oddity — and they remained so for many years afterward. The field of RNA biology was in ...